N10K

General Information


DRACP ID  DRACP01826

Peptide Name   N10K

Sequence  NQVSLTCLVK

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  AMPs

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10-Nex2 Mouse melanoma Carcinoma As shown in fig. 6, the peptide has anticancer activity Trypan Blue exclusion assay 12 h Patent
SK-MEL-28 Cutaneous melanoma Carcinoma As shown in fig. 6, the peptide has anticancer activity Trypan Blue exclusion assay 12 h Patent
SK-MEL-25 Melanoma Carcinoma As shown in fig. 6, the peptide has anticancer activity Trypan Blue exclusion assay 12 h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01826

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C47H85N13O15S

Absent amino acids  ADEFGHIMPRWY

Common amino acids  LV

Mass  126505

Pl  8.55

Basic residues  1

Acidic residues  0

Hydrophobic residues  4

Net charge  1

Boman Index  -450

Hydrophobicity  61

Aliphatic Index  136

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID WO2011/060393A1

Patent Title  Antimicrobial, Antiviral, Anticancer and Immunomodulatory Peptides and Uses Therefore

Other Iinformation  Patent Application; Family: 1s / 1ex; Family Jurisdictions: WO; Legal Status: Pending; Application No: 2010056763; Filed: Nov 15, 2010; Published: May 19, 2011; Earliest Priority: Nov 16, 2009

Other Published ID  US20090261738P20091116 




DRACP is developed by Dr.Zheng's team.